Why Might Rheumatoid Arthritis Treatment Need to Change Over Time?
The immune system attacks the joint lining.
It causes inflammation, causing damage to the joint.
It involves the joints of the hands, wrists, and feet.
The risk factors for developing rheumatoid arthritis-
Non–modifiable factors include-
- Age and sex – Women are more likely to develop arthritis compared to men.
The rheumatoid arthritis can affect people at any age, but the risk increases with the rising age.
- Family history and genetics –
If the disease runs in the family, it increases the risk of the person developing the disease.
Lifestyle risk factors include-
- Smoking – Tobacco smoking may increase the risk in people with genetic predisposition or worsen the symptoms.
- Obesity – Excessive weight is linked to an increased risk of inflammation and disease severity.
- Environmental pollutants – Long-term exposure to pollutants or toxins may increase the risk of developing RA.
The treatment plan for rheumatoid arthritis-
The treatment plan focuses on controlling joint inflammation and preventing further damage.
Key medicines include-
- Conventional DMARDs
- Biological DMARDs
- Targeted synthetic DMARDs
- NSAIDs and corticosteroids for symptomatic relief
At Aprazer Healthcare, we manufacture a range of rheumatology medicines.
As a rheumatology medicine manufacturer and exporter, we export drugs worldwide.
Why might I need to change the treatment plan?
The doctor must evaluate the patient’s condition and the drug response.
According to the condition, medicine may be added, or the dose may be adjusted.
The doctor must regularly assess disease activity, monitoring symptoms and side effects.
One must not stop medication on one’s own, even if one does not experience the symptoms.
Medication must not be stopped or changed without consulting the doctor.
The factors that are evaluated to change the medicine:
- Persistent and intolerable side effects.
- Underlying health changes
- Pregnancy
- Drug interactions
- Disease flare-ups
The common types and classifications of rheumatoid arthritis-
Seropositive Rheumatoid Arthritis-
It is a condition in which blood tests show a detection of RF, anti-citrullinated protein antibodies (ACPA), or both.
Seronegative Rheumatoid Arthritis-
The patients experience arthritis symptoms and show negative results for RF and anti-citrullinated protein antibodies (ACPA).
Juvenile idiopathic arthritis (JIA)-
It is an arthritis condition developed in childhood (below 16 years of age).
It must not be misunderstood as a young form of adult rheumatoid arthritis.
Elderly-Onset Rheumatoid Arthritis-
It is a chronic condition that occurs in older people.
Why trust rheumatology medicines manufacturer from Aprazer Healthcare?
Aprazer Healthcare is a pharmaceutical manufacturer specializing in rheumatology medicines.
We are a GMP-certified manufacturer.
We export medicines to countries in Asia, Africa, and the Americas.
Our product portfolio consists of:
- HQKAST 200 (Hydroxychloroquine Sulphate)
- Tofamark (Tofacitinib)